• The current review does not claim to be comprehensive and in particular has not considered commonly used topical agents including anthralin (dithranol), tar and topical corticosteroids, nor all variants of psoriasis (for example nail psoriasis, scalp psoriasis, generalised pustular psoriasis).
• Many psoriasis trials are too small and of too short a duration to be able to draw robust conclusions. Few trials record patients' own evaluations of treatment efficacy and tolerability. There is, however, a considerable amount of information to help guide practice.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.